Nuveen
CLRB icon

Nuveen’s Cellectar Biosciences CLRB Stock Holding History

Nuveen’s Portfolio CLRB Stock Details CLRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.18K Buy
+1,197
New +$2.96K ﹤0.01% 4835

Other funds holding CLRB

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
Key Financial Inc
Key Financial Inc West Chester, Pennsylvania $614M AUM 14.43% 1-Year Est. Return
Danske Bank
Danske Bank Copenhagen K, Denmark $50.1B AUM 35.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return

Nuveen's CLRB Position: Q3 2026 in Review

Nuveen opened a new position in Cellectar Biosciences (CLRB) in Q3 2026: 1,197 shares worth $2.18K. The stake represents ﹤0.01% of the portfolio and ranks #4835 among its holdings.

8 funds tracked by Wall St. Rank hold CLRB as of Q3 2026.

  • Nuveen held 1,197 shares of Cellectar Biosciences worth $2.18K as of Q3 2026.
  • Cellectar Biosciences was a new Nuveen position in Q3 2026.
  • Cellectar Biosciences made up ﹤0.01% of Nuveen's portfolio in Q3 2026, its #4835 holding.
  • 8 funds tracked by Wall St. Rank held Cellectar Biosciences as of Q3 2026.

Based on Nuveen's 13F filing for Q3 2026, filed 10 Nov 2026.